Enhanced Bioavailability of Tadalafil after Intranasal Administration in Beagle Dogs
- Document Type
- Publications · Journal Article
- Registered DB
- SCIEScopus
- Journal Ranking
- JCR Q1Scopus Q1
- Journal
- PHARMACEUTICS10(4) · 2018
- Citation
- Web of Science 14Scopus 16
- FWCI (Scopus)
- 0.97
- JCR IF
- JCR 2017 3.746
- ISSN
- 1999-4923
Authors
- Kim, Jeong-SooFirst authorDong-A ST Co. Ltd., Yongin, South Korea
- Kim, MinsooCorresponding authorCollege of Pharmacy, Pusan National University, Busan, South Korea
- Baek, In-HwanCollege of Pharmacy, Kyungsung University, Busan, South Korea
Abstract
Tadalafil is an oral selective phosphodiesterase type-5 inhibitor with demonstrated efficacy and safety that is used to treat erectile dysfunction. The purpose of this study is to compare the pharmacokinetic properties of tadalafil after conventional oral tablet administration and novel intranasal administration in beagle dogs. Fourteen 13-month-old male beagle dogs were randomly divided into two groups, and were given 5 mg tadalafil orally or intranasally in a parallel design. Blood samples were collected before and 0.5, 1, 1.5, 2, 4, 6, 8, 12, 24, and 36 h after administration. The plasma concentration of tadalafil was determined via liquid chromatography-tandem mass spectrometry (LC-MS/MS). The systemic exposure and absorption rate of tadalafil were significantly greater in the intranasal administration group than in the oral administration group. A one-compartment model with first-order absorption and elimination was sufficient to explain the pharmacokinetic characteristics observed after both oral and intranasal administration. This study indicates that the development of tadalafil nasal delivery systems is feasible and may lead to better results than the conventional oral route.
Keywords
tadalafilpharmacokineticsintranasalmodelingdogERECTILE DYSFUNCTIONIN-VITROORODISPERSIBLE FILMDRUG-DELIVERYSILDENAFILPHARMACOKINETICSFORMULATIONEFFICACYUDENAFILGEL
Identifiers
- Scopus EID
- 2-s2.0-85056146791
- WoS UID
- 000455853800025



Login
Back to Publication list